Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Home > Cartherics News > Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Karen Loudon2019-01-23T23:36:03+11:00January 23rd, 2019|

BD Biotech Daily Jan 23 – Cartherics

Victorian development biologists are gathering in August & Cartherics joins the intellectual party

July 22, 2021

By Leigh Dayton 22 July 2021 Cartherics is delighted to announce that it is a sponsor of the Australia and...

General In the media The Pipeline

Cartherics, ARMI and CCRM Australia announce new agreement for closer cooperation and collaboration

July 5, 2021

Cartherics Pty Ltd and the Australian Regenerative Medicine Institute (ARMI), including commercialisation initiative CCRM Australia, announced agreements for closer cooperation...

General In the media The Pipeline

Super-Charging the Immune System to Fight Cancer

June 28, 2021

Innovative immunotherapies for cancer are a step closer to reality thanks to a commercial licence agreement between Australia’s Cartherics Pty....

Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Share This Post